Building a Great Scientific Abstract: A Quick Checklist

      It should never be a rushed afterthought. An awful lot is riding on the quality of scientific abstracts. Most readers will rely on that summary, delving in no further. And a conference

An Author Rights Perspective on Scientific Editors

  By Hilda Bastian   What should scientific editors be able to do well? We would all be able to agree easily on some basics. Last year, a group led by David Moher and colleagues

The Case of the Missing Neuro Drug Trials

0000-0002-8715-2896     The case of the missing neurological drug trials remains shrouded in mystery. Nearly 48,000 people took part in these trials for new drugs for multiple sclerosis, stroke, Alzheimer disease, migraine, epilepsy, insomnia, and Parkinson

Science and the Rise of the Co-Authors

Ensemble-930x1024  Leonhart Fuchs credited his illustrator collaborators in De Historia Stirpium, 1542 Physicists set a new record this year for number of co-authors: a 9-page report needed an extra 24 pages to list its 5,154 authors.

Why Aren’t We All Machine-Friendly Researchers?

  I blame the writing and research impact advice we get. At least in part. It doesn’t prepare us as well for our relationship with machines as it could. When we’re told to think of “the

The post Why Aren’t We All Machine-Friendly Researchers? appeared first on PLOS Blogs Network.

Post-SPRINT Trial Headaches

  On 11 September, some 9,300 participants in the SPRINT trial were sent a letter from the National Institutes of Health (NIH). The letter told them the part of the trial where they needed to meet a set blood pressure target is … Continue reading »

The post Post-SPRINT Trial Headaches appeared first on PLOS Blogs Network.

5 Key Things to Know About Data on Adverse Effects

  The potential harms of interventions are tricky to get a handle on. Our feelings about them are, too. It wouldn’t be easy – even if we didn’t have to deal with people trying to beat up, or minimize, the … Continue reading »

The post 5 Key Things to Know About Data on Adverse Effects appeared first on PLOS Blogs Network.

Another 5 Things to Know About Meta-Analysis

  Last year I wrote a post of “5 Key Things to Know About Meta-Analysis”. It was a great way to focus – but it was hard keeping to only 5. With meta-analyses booming, including many that are poorly done or misinterpreted, … Continue reading »

The post Another 5 Things to Know About Meta-Analysis appeared first on PLOS Blogs Network.

Rifts and Bright Spots in Evidence-Based Medicine

It all starts and ends with the patient. That was a strong message from the first day of Evidence Live. Trisha Greenhalgh walked that walk on day 2. She showed the limits of evidence-based medicine (EBM) with the story of one patient’s … Continue reading »

The post Rifts and Bright Spots in Evidence-Based Medicine appeared first on PLOS Blogs Network.

Study Report, Study Reality, and the Gap Between

We take mental shortcuts about research reports. “I read a study,” we say. We don’t only talk about them as though they are the study – we tend to think of them that way, too. And that’s risky. Even the … Continue reading »

The post Study Report, Study Reality, and the Gap Between appeared first on PLOS Blogs Network.